Wednesday, April 25, 2012

“The old model was Pfizer hires Joe. The new model is Pfizer hires the entire department of biochemistry… I don’t see that being managed by disclosures of any sort.”

Don’t ban conflicts of interest; manage them, say universities and journals, which means disclosing such conflicts. Yet there’s “ritual ignoring of disclosures,” writes one observer, which makes them public-relations terrific and actual-world pointless.


Posted via email from Jack's posterous

No comments: